Literature DB >> 30104281

Case Report of Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Ventriculitis with Intravenous plus Intraventricular Tigecycline.

Yan Liu1,2, Zenghui Pu3, Maomao Zhao3.   

Abstract

Entities:  

Keywords:  Acinetobacter baumannii; extensively drug resistant; intraventricular; tigecycline

Mesh：

Substances：

Year:  2018        PMID： 30104281      PMCID： PMC6201126          DOI： 10.1128/AAC.01625-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin.

Authors:  G De Pascale; A Pompucci; R Maviglia; T Spanu; G Bello; A Mangiola; G Scoppettuolo
Journal:  Minerva Anestesiol       Date:  2010-05-06       Impact factor: 3.051

Review 2.  Polymyxins for CNS infections: Pharmacology and neurotoxicity.

Authors:  Tony Velkov; Chongshan Dai; Giuseppe D Ciccotosto; Roberto Cappai; Daniel Hoyer; Jian Li
Journal:  Pharmacol Ther       Date:  2017-07-25       Impact factor: 12.310

3.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 4.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

5.  Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014.

Authors:  F-P Hu; Y Guo; D-M Zhu; F Wang; X-F Jiang; Y-C Xu; X-J Zhang; C-X Zhang; P Ji; Y Xie; M Kang; C-Q Wang; A-M Wang; Y-H Xu; J-L Shen; Z-Y Sun; Z-J Chen; Y-X Ni; J-Y Sun; Y-Z Chu; S-F Tian; Z-D Hu; J Li; Y-S Yu; J Lin; B Shan; Y Du; Y Han; S Guo; L-H Wei; L Wu; H Zhang; J Kong; Y-J Hu; X-M Ai; C Zhuo; D-H Su; Q Yang; B Jia; W Huang
Journal:  Clin Microbiol Infect       Date:  2016-03       Impact factor: 8.067
  5 in total
  3 in total

1.  Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii with multi-route tigecycline: A case report.

Authors:  Wei Li; Dan-Dong Li; Bo Yin; Dong-Dong Lin; Han-Song Sheng; Nu Zhang
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

2.  Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature.

Authors:  Ziyu Li; Yuling An; Lijuan Li; Huimin Yi
Journal:  Infect Drug Resist       Date:  2022-03-31       Impact factor: 4.003

3.  Extensive drug resistant (XDR) Acinetobacter baumannii parappendicular-related infection in a hydrocephalus patient with ventriculoperitoneal shunt: a case report.

Authors:  Cucunawangsih Cucunawangsih; Akhil Deepak Vatvani; Kalis Waren
Journal:  Pan Afr Med J       Date:  2020-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.